Back to Search
Start Over
Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.
- Source :
-
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2001 Jun 15; Vol. 21 (12), pp. 4390-9. - Publication Year :
- 2001
-
Abstract
- In the striatum, dopamine D(1) and adenosine A(2A) receptors stimulate the production of cAMP, which is involved in neuromodulation and long-lasting changes in gene expression and synaptic function. Positive coupling of receptors to adenylyl cyclase can be mediated through the ubiquitous GTP-binding protein Galpha(S) subunit or through the olfactory isoform, Galpha(olf), which predominates in the striatum. In this study, using double in situ hybridization, we show that virtually all striatal efferent neurons, identified by the expression of preproenkephalin A, substance P, or D(1) receptor mRNA, contained high amounts of Galpha(olf) mRNA and undetectable levels of Galpha(s) mRNA. In contrast, the large cholinergic interneurons contained both Galpha(olf) and Galpha(s) transcripts. To assess the functional relationship between dopamine or adenosine receptors and G-proteins, we examined G-protein levels in the striatum of D(1) and A(2A) receptor knock-out mice. A selective increase in Galpha(olf) protein was observed in these animals, without change in mRNA levels. Conversely, Galpha(olf) levels were decreased in animals lacking a functional dopamine transporter. These results indicate that Galpha(olf) protein levels are regulated through D(1) and A(2A) receptor usage. To determine the functional consequences of changes in Galpha(olf) levels, we used heterozygous Galpha(olf) knock-out mice, which possess half of the normal Galpha(olf) levels. In these animals, the locomotor effects of amphetamine and caffeine, two psychostimulant drugs that affect dopamine and adenosine signaling, respectively, were markedly reduced. Together, these results identify Galpha(olf) as a critical and regulated component of both dopamine and adenosine signaling.
- Subjects :
- Amphetamine pharmacology
Animals
Caffeine pharmacology
Carrier Proteins genetics
Carrier Proteins metabolism
Central Nervous System Stimulants pharmacology
Dopamine Plasma Membrane Transport Proteins
Heterotrimeric GTP-Binding Proteins genetics
Heterozygote
In Situ Hybridization
Male
Mice
Mice, Knockout
Motor Activity drug effects
Motor Activity genetics
Neurons classification
Neurons metabolism
Organ Specificity
Protein Isoforms genetics
Protein Isoforms metabolism
RNA, Messenger metabolism
Rats
Rats, Sprague-Dawley
Receptor, Adenosine A2A
Receptors, Dopamine D1 deficiency
Receptors, Dopamine D1 genetics
Receptors, Purinergic P1 deficiency
Receptors, Purinergic P1 genetics
Adenosine metabolism
Corpus Striatum metabolism
Dopamine metabolism
Heterotrimeric GTP-Binding Proteins metabolism
Membrane Glycoproteins
Membrane Transport Proteins
Nerve Tissue Proteins
Receptors, Dopamine D1 metabolism
Receptors, Purinergic P1 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1529-2401
- Volume :
- 21
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- The Journal of neuroscience : the official journal of the Society for Neuroscience
- Publication Type :
- Academic Journal
- Accession number :
- 11404425